Latest News & Features
Americas
Law firm McGuire Woods has hired IP litigators Michael Nutter and Merritt Westcott, for its Chicago and Houston offices, respectively. 15 September 2022
Biotechnology
Kansas-based company wins block on infringing plant-based albumins | Genetically programmed rice expresses human proteins used in immunotherapy drugs, gene therapies and vaccines. 15 September 2022
article
Patent law firm EIP has opened a new regional hub in Stockholm, Sweden with a focus on the life sciences. 13 September 2022
Americas
Deal set to enable faster use of artificial intelligence in drug discovery | Planned AI models to identify novel targets and establish biomarkers of disease. 13 September 2022
Americas
Gilead had filed patent infringement proceedings lawsuit against five companies | Drug makers will receive non-exclusive licences starting from Halloween 2031. 13 September 2022
Americas
A split Federal Circuit revived a 2017 jury verdict that Teva had infringed GSK drug | Israeli pharma firm warns of threat to availability of low-cost generic medicines. 8 September 2022
article
Law firm Hogan Lovells has hired Chris Natkanski to its global regulatory and intellectual property, media, and technology practice group in Boston. 8 September 2022
Big Pharma
Illumina bid would have “stifled innovation” | EU said Illumina was the "unrivalled supplier” of next-generation sequencing systems for genetic and genomic analysis. 8 September 2022
Americas
Mylan and Edwards Lifesciences argue that the controversial rule safeguards poor-quality patents | US v Arthrex conferred increased authority to Vidal over PTAB decisions. 6 September 2022
Big Pharma
Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA. 6 September 2022